Bisphosphonates and Atypical Fractures of Femur

  • Yli-Kyyny T
Citations of this article
Mendeley users who have this article in their library.


Bisphosphonates are the most widely prescribed medicines for the treatment of osteoporosis and have generally been regarded as well-tolerated and safe drugs. Since 2005, there have been numerous case reports about atypical fractures of the femur linked to long-term treatment of osteoporosis with bisphosphonates. Some attempts to characterize pathophysiology and epidemiology of these fractures have been published as well. However, as the American Society for Bone and Mineral Research (ASBMR) concluded in their task force report, the subject warrants further studies.




Yli-Kyyny, T. (2011). Bisphosphonates and Atypical Fractures of Femur. Journal of Osteoporosis, 2011, 1–5.

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free